Sunday, July 6, 2025
25 °c
Agartala
enewstime
No Result
View All Result
No Result
View All Result
enewstime
  • Advertising Policy
  • Contact Enewstime
  • Cookie Policy
  • Disclaimer
  • ENEWSTIME Homepage
  • Features
  • Latest Tenders
  • News
  • Privacy Policy
  • Tenders
  • Terms of Use
Home Health

Common gut bacteria can make diabetes, cancer drugs less effective: Study

IANS by IANS
April 3, 2025
in Health
Common gut bacteria can make diabetes, cancer drugs less effective: Study
31
VIEWS
Share on FacebookShare on Twitter

New Delhi, April 3 (IANS) Common gut bacteria can metabolise some oral medications potentially rendering these important drugs against migraines, depression, type 2 diabetes, and prostate cancer less effective, according to a study on Thursday.

Researchers from the University of Pittsburgh and Yale University in the US showed that gut bacteria metabolises oral drugs that target cellular receptors called GPCRs.

Drugs that act on GPCRs, or G protein-coupled receptors, include more than 400 medications approved by the US Food and Drug Administration (FDA) for the treatment of many common conditions such as migraines, depression, type 2 diabetes, prostate cancer, and more.

“Understanding how GPCR-targeted drugs interact with human gut microbiota is critical for advancing personalised medicine initiatives,” said Qihao Wu, Assistant Professor at the Pitt School of Pharmacy.

“This research could help open up new avenues for drug design and therapeutic optimisation to ensure that treatments work better and safer for every individual,” Wu said.

The effectiveness of a drug varies from person to person, influenced by age, genetic makeup, diet and other factors.

Recently, researchers discovered that microbes in the gut can also metabolise orally administered drugs. It breaks down the compounds into different chemical structures which then alters the drugs’ efficacy.

To learn more about which gut bacteria metabolises which drugs, the team built a synthetic microbial community composed of 30 common bacterial strains found in the human gut.

In the lab study, they added each of the 127 GPCR-targeting drugs individually to tubes containing the bacteria.

The experiment showed that the bacterial mix metabolised 30 of the 127 tested drugs, 12 of which were heavily metabolised. This meant that concentrations of the original drug were greatly depleted because they were transformed into other compounds.

Overall, the findings, published in the journal Nature Chemistry, suggest that “specific gut bacteria could make GPCR-targeting drugs less effective by transforming them into other compounds,” the team said. The team urged for more research to understand the potential impact in people and that patients shouldn’t stop taking or, change their medication without consulting their provider.

–IANS

rvt/

*Except for the headings & sub-headings, this story has not been edited by The enewstime.in and has been published from IANS feed.

Related Posts

Covid vaccine row: Piyush Goyal slams K'taka CM for insulting Indian scientists, drugmakers
Health

Covid vaccine row: Piyush Goyal slams K'taka CM for insulting Indian scientists, drugmakers

July 5, 2025
Should anti-ageing medicines be banned in India?
Health

Should anti-ageing medicines be banned in India?

July 5, 2025
Anatomy of medical college scam: Hawala deals kept bribes flowing from colleges to regulators
Health

Anatomy of medical college scam: Hawala deals kept bribes flowing from colleges to regulators

July 5, 2025
Multi-city CBI raids: Bribes, godman’s role exposed in medical college regulation; 6 held
Health

Multi-city CBI raids: Bribes, godman’s role exposed in medical college regulation; 6 held

July 5, 2025
Infections due to new Covid strains not severe, we’re monitoring: ICMR-NIV Director
Health

Infections due to new Covid strains not severe, we’re monitoring: ICMR-NIV Director

June 18, 2025
ICAR-NIHSAD Bhopal designated as containment facility for Rinderpest virus
Health

ICAR-NIHSAD Bhopal designated as containment facility for Rinderpest virus

June 16, 2025
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT
D-2050 D-2050 D-2050
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT

About us

Enewstime.in is run by an individual – a Journalist by profession of Tripura with the active help of several journos including senior journalists of the State. On top of that, Enewstime.in being a subscriber of IANS news agency, we have plenty of multi-choice topics to offer to our esteemed readers. Enewstime.in is a venture reach global audience from a tiny State Tripura.

Latest News

Resumption of FII buying hinges on India-US trade deal, Q1 results

Covid vaccine row: Piyush Goyal slams K'taka CM for insulting Indian scientists, drugmakers

2nd Test: Had to check with Harry Brook if I was facing a hat-trick ball, reveals Jamie Smith

Should anti-ageing medicines be banned in India?

Release of Anushka Shetty, Vikram Prabhu-starrer 'Ghaati' postponed

IndusInd Bank's net advances dip nearly 4 pc in Q1, deposits also decline

Contact us

19, Old Thana Road. Banamalipur. PO. Agartala. Pin code 799001. Tripura (West), India.

Email: enewstime2017@gmail.com

Wa: 8794548041

© 2025 Designed & Developed with ❤️ by Provibe Media LLP

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result

© 2025 Designed & Developed with ❤️ by Provibe Media LLP